KARACHI, Pakistan – Facing a chronic shortage of regulations, the biopharmaceutical industry in Pakistan is struggling to get traction despite widespread need and huge market potential. With a population that is rapidly approaching 200 million, Pakistan's pharmaceutical sector sees high growth potential, but it's held back by a lack of regulations that often translates into chronic shortages of essential medicines.